Outlook Therapeutics, Inc.
OTLK· Nasdaq
OTLKOutlook Therapeutics, Inc.
Filed Aug 14, 2017 · 10-Q · 45 days after period end · 0001571049-17-007497
| Metric | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|
| Revenue | $303.14K | $494.89K | $1.29M |
| Net Income | -$5.33M | -$22.33M | -$11.34M |
| EPS Diluted | -$0.22 | -$1.60 | -$1.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Outlook Therapeutics, Inc. · CIK 1649989 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end
